Literature DB >> 32349976

Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.

Alice Bhasale1, Barbara Mintzes2,3, Ameet Sarpatwari4.   

Abstract

Entities:  

Year:  2020        PMID: 32349976     DOI: 10.1136/bmj.m1107

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  1 in total

Review 1.  Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs.

Authors:  Linda M Hunt; Elisabeth A Arndt; Hannah S Bell; Heather A Howard
Journal:  J Bioeth Inq       Date:  2021-09-06       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.